GB201518002D0 - Ketamine for the treatment of somatoform pain disorder - Google Patents

Ketamine for the treatment of somatoform pain disorder

Info

Publication number
GB201518002D0
GB201518002D0 GBGB1518002.9A GB201518002A GB201518002D0 GB 201518002 D0 GB201518002 D0 GB 201518002D0 GB 201518002 A GB201518002 A GB 201518002A GB 201518002 D0 GB201518002 D0 GB 201518002D0
Authority
GB
United Kingdom
Prior art keywords
ketamine
treatment
pain disorder
somatoform pain
somatoform
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1518002.9A
Other versions
GB2543484A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hermann Dr Med L
Original Assignee
Hermann Dr Med L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hermann Dr Med L filed Critical Hermann Dr Med L
Priority to GB1518002.9A priority Critical patent/GB2543484A/en
Publication of GB201518002D0 publication Critical patent/GB201518002D0/en
Publication of GB2543484A publication Critical patent/GB2543484A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GB1518002.9A 2015-10-12 2015-10-12 Ketamine for the treatment of somatoform pain disorder Withdrawn GB2543484A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1518002.9A GB2543484A (en) 2015-10-12 2015-10-12 Ketamine for the treatment of somatoform pain disorder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1518002.9A GB2543484A (en) 2015-10-12 2015-10-12 Ketamine for the treatment of somatoform pain disorder

Publications (2)

Publication Number Publication Date
GB201518002D0 true GB201518002D0 (en) 2015-11-25
GB2543484A GB2543484A (en) 2017-04-26

Family

ID=55130908

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1518002.9A Withdrawn GB2543484A (en) 2015-10-12 2015-10-12 Ketamine for the treatment of somatoform pain disorder

Country Status (1)

Country Link
GB (1) GB2543484A (en)

Also Published As

Publication number Publication date
GB2543484A (en) 2017-04-26

Similar Documents

Publication Publication Date Title
IL249065A0 (en) Combination therapies for the treatment of cancer
PL3964213T3 (en) Treatment of conduct disorder
IL259996A (en) Combinations for the treatment of cancer
LT3122358T (en) Combinations of fgfr- and cmet-inhibitors for the treatment of cancer
HK1254882A1 (en) Combination therapies for treatment of cancer
PL3622953T3 (en) Combination treatment of cancer
GB201608885D0 (en) Treatment
GB201502137D0 (en) Treatment
GB201522243D0 (en) Treatment
HK1249865B (en) Treatment of pain
HK1252245A1 (en) Nucleotides for the treatment of cancer
HK1248130A1 (en) Composition for treating pain
GB201508841D0 (en) Treatment
GB201604658D0 (en) Treatment for pain
GB201503008D0 (en) Treatment
GB201518002D0 (en) Ketamine for the treatment of somatoform pain disorder
GB201617107D0 (en) Treatment
GB201612260D0 (en) Treatment
GB201612193D0 (en) Treatment
GB201609683D0 (en) Treatment
GB201505205D0 (en) Treatment for pain
GB201504688D0 (en) Treatment for pain
GB201518349D0 (en) Treatment
GB201515739D0 (en) Treatment
GB201512723D0 (en) Treatment of cancer

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)